Shiva Saghafi

561 total citations
24 papers, 222 citations indexed

About

Shiva Saghafi is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Shiva Saghafi has authored 24 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 7 papers in Hematology and 5 papers in Genetics. Recurrent topics in Shiva Saghafi's work include Immunodeficiency and Autoimmune Disorders (14 papers), Immune Cell Function and Interaction (7 papers) and Blood disorders and treatments (5 papers). Shiva Saghafi is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (14 papers), Immune Cell Function and Interaction (7 papers) and Blood disorders and treatments (5 papers). Shiva Saghafi collaborates with scholars based in Iran, Germany and Sweden. Shiva Saghafi's co-authors include Zahra Pourpak, Asghar Aghamohammadi, Nima Rezaei, Gholam Ali Kardar, Nima Parvaneh, Taher Cheraghi, Sina Abdollahzade, Mostafa Moin, Nima Pouladi and Zahra Alizadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, Science Advances and Clinical Immunology.

In The Last Decade

Shiva Saghafi

22 papers receiving 217 citations

Peers

Shiva Saghafi
Comparison fields: 5 of 54
  • Immunology 165
  • Genetics 58
  • Hematology 43
  • Pulmonary and Respiratory Medicine 31
  • Genetics 29
Replace Zoltán Derzsy with:
Zoltán Derzsy Hungary
Daniel Suez United States
Nerea Domínguez‐Pinilla Spain
Himmet Haluk Akar Türkiye
Nikita Raje United States
Vasilis Sitras Norway
T. Víkingsdóttir Iceland
May Lee Tjoa Netherlands
Kiran Patel United States
Zoltán Derzsy Hungary View profile →
Citations per field, relative to Shiva Saghafi
Shiva Saghafi · 1×
Citations per year, relative to Shiva Saghafi
Shiva Saghafi · 1×

Countries citing papers authored by Shiva Saghafi

Since Specialization
Citations

This map shows the geographic impact of Shiva Saghafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiva Saghafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiva Saghafi more than expected).

Fields of papers citing papers by Shiva Saghafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiva Saghafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiva Saghafi. The network helps show where Shiva Saghafi may publish in the future.

Co-authorship network of co-authors of Shiva Saghafi

This figure shows the co-authorship network connecting the top 25 collaborators of Shiva Saghafi. A scholar is included among the top collaborators of Shiva Saghafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiva Saghafi. Shiva Saghafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 1
4 3
5 2
6 19
7
Mannose-binding Lectin Deficiency in Patients with a History of Recurrent Infections.
7
8 5
9
The Effect of IL-22 and IL-28 in Induction of Type 1 Regulatory T (Tr1) Cells.
2
10 15
11
Development of a new immunochromatographic assay using gold nanoparticles for screening of IgA deficiency.
7
12
The diagnosis of hyper immunoglobulin e syndrome based on project management.
3
13
Polymorphisms and serum level of mannose-binding lectin: an Iranian survey.
7
14
Mannan-binding lectin serum levels in 593 healthy Iranian children and adults.
4
15
Effect of anti-epileptic drugs on serum immunoglobulin levels in children.
14
16 21
17
Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
2
18
Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases.
41
19
Human leukocyte antigens (HLA) associated with selective IgA deficiency in Iran and Sweden.
13
20
Evaluation of humoral immune function in patients with bronchiectasis.
16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026